Notes to the Accounts (continued)

17. Investments in subsidiaries (continued) The summarised financial information of the subsidiary undertakings that are material to the Group is provided below:

a) Trading subsidiaries – activities for generating funds

Cancer Research UK Trading Ltd

2011 £000

Turnover Cost of sales

Interest receivable Net operating costs

Profit on ordinary activities before Gift Aid and taxation Gift Aid payable to Cancer Research UK Taxation

Retained profit for the year Assets Liabilities Net assets b) Trading subsidiaries – activities in furtherance of the Group’s objects

Cancer Research Technology Ltd

2011 £000

Turnover

Cost of sales Other income Interest payable Interest receivable

Profit on ordinary activities before Gift Aid and taxation Gift Aid payable to Cancer Research UK Taxation

Retained profit for the year Assets Liabilities Net assets 32,722

(30,622) 32

(19) 64

2,177

(1,137) –

1,040 27,154

(16,966) 10,118

2010 £000

32,755

(30,359) 104

(19) 67

2,548

(1,563) –

985 28,887

(19,739) 9,148

Cancer Research Technology Inc

2011 £000

390

(341) – – –

54 –

(10) 44

213

(40) 173

Beatson Technology Limited is a wholly-owned subsidiary of the Beatson Institute for Cancer Research. The company was established to undertake commercial developments arising as a by-product of the Institute’s medical research activities. Currently, the company has negligible trading activities.

2010 £000

414

(403) – – –

11 –

(3) 8

202

(33) 169

23,017

(22,058) 27

(69) 917

(925) 8

– 6,275

(6,275) –

2010 £000

23,767

(22,575) 46

(88) 1,150

(1,150) –

– 7,145

(7,145) –

44 / Annual Report and Accounts / Notes to the Accounts